Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation.
about
Surgical Ablation of Atrial FibrillationAtrial fibrillation therapy now and in the future: drugs, biologicals, and ablationHybrid ablation for atrial fibrillation: a systematic reviewAtrial fibrillation: review of current treatment strategiesHybrid approaches in atrial fibrillation ablation: why, where and who?Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation.Minimally Invasive Atrial Fibrillation Surgery: Hybrid Approach.Pericardial adhesions as a consequence of cryoballoon ablation detected during the hybrid AF ablation procedure.Surgical options in atrial fibrillation.Sequential hybrid procedure for persistent atrial fibrillation.Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of lone atrial fibrillation.Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long-term observationCatheter Ablation for Persistent and Long-Standing Persistent Atrial FibrillationTotal endoscopic ablation of patients with long-standing persistent atrial fibrillation: a randomized controlled study.Novel Interventional Strategies for the Treatment of Atrial FibrillationBreakthroughs in hybrid management of stand-alone AF.Surgical options for treatment of atrial fibrillation.Hybrid epicardial and endocardial ablation of atrial fibrillation: is ablation on two sides of the atrial wall better than one?[Hybrid operation theatre from the point of view of cardiac surgery. The future for the heart team].Effectiveness and safety of simultaneous hybrid thoracoscopic endocardial catheter ablation of atrial fibrillation in obese and non-obese patients.European prospective multicentre study of hybrid thoracoscopic and transcatheter ablation of persistent atrial fibrillation: the HISTORIC-AF trial.The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysis.Two-staged hybrid ablation of non-paroxysmal atrial fibrillation: clinical outcomes and functional improvements after 1 year.Minimally Invasive Epicardial Surgical Ablation Alone Versus Hybrid Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis.Midterm outcomes of two-staged hybrid ablation of persistent and long-standing persistent atrial fibrillation using the versapolar epicardial surgical device and subsequent catheter ablation.Staged hybrid procedure in persistent atrial fibrillation: safety, efficacy, and atrial tachyarrhythmia.The absence of effect of ganglionated plexi ablation on heart rate variability parameters in patients after thoracoscopic ablation for atrial fibrillation.Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial.Reduction of Arrhythmia Burden and Reverse Remodeling in Patients with Persistent Atrial Fibrillation and Severe Atrial Remodeling: The Benefits of Hybrid Ablation.Repeat Procedures After Hybrid Thoracoscopic Ablation in the Setting of Longstanding Persistent Atrial Fibrillation: Electrophysiological Findings and 2-Year Clinical Outcome
P2860
Q26797435-EF870058-22AC-4579-8073-418E7394997CQ26864767-F7609B1D-3968-449F-BAE0-E44C1035A501Q28071454-7058AABF-30FD-49A0-BDE8-E4B6AABC8A43Q28073181-97C28627-201D-4655-B5DD-7337B323C280Q28080696-63A40F10-9B6B-4CCA-AE28-5A2A3E4B8382Q30101004-B08658EC-01A2-4C04-90C5-9BE98EAC2E36Q30276896-D6EA5F91-6752-4D62-9119-0E9AF0629E27Q30847452-B244CF68-4FA6-4335-8362-ABE71177F6B7Q35062034-A3627ECA-041A-4942-962A-4A83A880FCC3Q35354318-89BE3540-8F56-44CB-B870-68FCE9F172C6Q37523132-9EB481A9-E794-4A1E-8EEF-531A4223036FQ37549314-B6B5F753-9F8A-41EC-92F8-925709320B52Q37723889-51E51478-37CF-4A99-A767-6215275B7345Q38393779-A6727211-6084-49D7-9692-F7401971BC35Q38893587-6F924C3A-72CC-466C-ADA4-A1F63546197FQ41849053-7E04E272-7B70-414F-9B22-48E125AF47A0Q41895471-345BB271-9F82-4A83-90F2-B8615AA306D0Q43226641-49164E91-73EC-4E6F-85CB-8299CCDE221CQ46562123-2F99F558-DFC8-4000-8410-48A242BFCE0AQ47103051-2F3D55E7-BE7F-45A4-8B48-60C2A6C5BAD9Q47182974-44AB5393-7293-4A5A-8D2C-5196763D5764Q47214115-939A0AE1-7390-4B0E-85EB-052709FC55BAQ47429445-D7453145-B7DF-46E9-8B80-9E112BB4EFA9Q47438000-9B0E669B-281C-40F1-8FCA-9D37D817F998Q47664301-655C8140-2784-457B-84E1-040B741D39F3Q49235722-195FFABB-88BD-4FFE-B971-6A6A0154C357Q49444074-89EDBB4A-C33B-4982-8C20-67F34E33A9DFQ49843168-DBF58915-B22E-4047-8988-D5078C2250DAQ53644788-7B09B223-00D9-4B12-B9AD-4FB42365D661Q57676557-3CEFC768-AF6D-4363-97D8-A8F116A30BAB
P2860
Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation.
@en
type
label
Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation.
@en
prefLabel
Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation.
@en
P2093
P2860
P921
P356
P1476
Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation
@en
P2093
Francis Wellens
Hanry J G M Crijns
Henrica N A M Van Breugel
Jos G Maessen
Laurant Pison
Mark La Meir
Orlando Parise
P2860
P304
P356
10.1093/EJCTS/EZT385
P577
2013-07-31T00:00:00Z